STAY INFORMED. VISIT NHIA.ORG/COVID19 FOR INFORMATION AND RESOURCES ABOUT CORONAVIRUS DISEASE (COVID-19).
Alexandria, Va. (February 23, 2022) — The National Home Infusion Association (NHIA) is pleased to announce the 2022 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals. The program is administered and funded by the National Home Infusion Foundation (NHIF), thanks to a generous contribution from Integrated Medical Systems, Inc. (IMS), the 2022 sponsor of the NHIA Fellow Program.
The NHIA Fellow Program aims to advance the home and alternate site infusion profession by recognizing the contributions and achievements of highly accomplished individuals. NHIA Fellow status is awarded to members who have successfully demonstrated a commitment to the field of home infusion for at least 7 years, have a record of sustained involvement and leadership within NHIA, and have been actively involved in educating practitioners and others.
“Congratulations to this year’s fellows. This program was created to recognize individual contributions, accomplishments, and expertise in home and alternate site infusion and once again, we are impressed with the caliber of experience, leadership, and commitment embodied in the 2022 group of FNHIA recipients,” said NHIA’s President and CEO Connie Sullivan, BSPharm.
Those selected for the FNHIA program include: Brett Benfield, Penny Allen, Cheryl Gast-Whitaker, Cynde Derryberry, Robert Buzas, Pammi Jo Farren, and Glenel Tillich.
These industry professionals were selected as part of a competitive application process, which included an extensive review of their professional accomplishments and letters of recommendation. These individuals hold varied positions within the home and alternate site infusion industry, including pharmacists, nurses, technicians, and non-clinical, sales, and administration professionals.
For more information about the program, visit www.nhia.org/nhif_fellow-program.
Thank you to Integrated Medical Systems, Inc. for their generous sponsorship of the FNHIA program.
###
NHIA is a trade association that represents companies that provide infusion therapy to patients in their homes, as well as companies that manufacture and supply infusion and specialty pharmacy products. The association’s mission is to provide advocacy, education, and resources to the home and specialty infusion community so the patients they serve can lead healthy, independent lives. Infusion therapy involves patient-specific compounded medications, supplies, and a range of pharmacy, nursing, and other clinical services for delivering care to patients in the home setting. For more information, visit www.nhia.org.
###
NHIA submitted comments pointing out the advantages of home-based administration of subcutaneous Ig (SCIG) for chronic inflammatory demyelinating polyneuropathy (CIPD).
NHIA submitted comments on a CMS proposed rule (CMS-1770-P) that would affect Medicare payments and coverage of COVID-19 vaccines and monoclonal antibodies (mAbs) and coding and billing requirements related to the use of single dose containers and drug waste.
As part of a strategic focus on promoting health equity, The National Home Infusion Foundation (NHIF) recently adopted standardized categories for race and ethnicity data collection and is encouraging all providers to include voluntary questions to capture this data. NHIF will utilize this data throughout its projects to evaluate equitable access to infusion treatments in alternate sites.
© 2022, National Home Infusion Association
All Rights Reserved by NHIA
